Jacobio Competitors and Similar CompaniesClear all
Jacobio's competitors and similar companies include Kite Pharma, Luye Pharma, United Therapeutics and Achieve Life Sciences.
 Jacobio Jacobio Pharmaceuticals Group (北京加科思新药研发有限公司, formerly known as Jacobio (Cay) Pharmaceuticals) is a pharmaceutical company that provides therapy solutions. |  Luye Pharma Luye Pharma Group (绿叶制药) is a pharmaceutical company that develops, manufactures, and sells medications. |  United Therapeutics United Therapeutics is a biotechnology company that develops and manufactures pharmaceutical products for pulmonary arterial hypertension and certain cancers. |  Achieve Life Sciences Achieve Life Sciences is a biopharmaceutical company that develops and commercializes therapies that address treatment resistance in cancer patients. | ||
Founding Date | Founding Date 2015 | Founding Date 2009 | Founding Date 1994 | Founding Date 1996 | Founding Date 1995 |
Type | Type Public | Type Subsidiary | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Beijing, CN HQ Beijing, CN Beijing, CN Shanghai, CN Lexington, US | Locations Santa Monica, US HQ Hoofddorp, NL London, GB El Segundo, US Emeryville, US Frederick, US Oceanside, US see more | Locations CN HQ | Locations Silver Spring, US HQ Durham, US Jacksonville, US Manchester, US Melbourne, US Washington, US | Locations Seattle, US HQ Vancouver, CA Bothell, US Bothell, US |
Employees | Employees 257 | Employees 3,9671% decrease | Employees 5,150 | Employees 1,16819% increase | Employees 148% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 15.7 b | Valuation ($) 166.2 m |
Financial | |||||
Revenue (est.) | Revenue (est.) ¥53.5m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) ¥6.3b (FY, 2025) | Revenue (est.) $3.2b (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods ¥593k (FY, 2025) | Cost of goods N/A | Cost of goods ¥1.3b (FY, 2025) | Cost of goods $384.4m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit ¥56.8m (FY, 2025) | Gross profit N/A | Gross profit ¥5.1b (FY, 2025) | Gross profit $2.8b (FY, 2025) | Gross profit N/A |
Net income | Net income (¥146m) (FY, 2025) | Net income N/A | Net income ¥705.7m (FY, 2025) | Net income $1.3b (FY, 2025) | Net income ($54.6m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 85.3m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 10m |
For sources of this data, please see the company profile
View Company Profiles
Kite Pharma
HQ
Santa Monica, US
Kite Pharma is a company developing cancer immunotherapy products based on cell therapy.
View companyLuye Pharma
HQ
CN
Employees
5,150
Luye Pharma Group (绿叶制药) is a pharmaceutical company that develops, manufactures, and sells medications.
View companyUnited Therapeutics
HQ
Silver Spring, US
Employees
1,168↑ 19% increase
United Therapeutics is a biotechnology company that develops and manufactures pharmaceutical products for pulmonary arterial hypertension and certain cancers.
View companyAchieve Life Sciences
HQ
Seattle, US
Employees
14↑ 8% increase
Achieve Life Sciences is a biopharmaceutical company that develops and commercializes therapies that address treatment resistance in cancer patients.
View company